11 studies found for:    Open Studies | "Sweetening Agents"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Determination of the Glycemic Index and the Insulinemic Index of a Sweetener Syrup
Condition: Healthy Volunteers
Interventions: Other: experimental sweetener syrup 1;   Other: classical sugar syrup;   Other: experimental sweetener syrup 2
2 Recruiting The Effects of Oral Glucose Compared to Sweetener Drinking on Hormonal/Metabolic Responses
Condition: Obesity
Interventions: Other: glucose;   Other: sweetner
3 Recruiting Metabolic Effects of Non-Nutritive Sweeteners
Condition: Healthy Volunteers
Intervention: Other: Sucralose
4 Recruiting Investigation of Tibolone and Escitalopram in Perimenopausal Depression
Condition: Perimenopausal Depression
Interventions: Drug: Tibolone;   Drug: Escitalopram;   Drug: Natvia
5 Unknown  The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks
Conditions: Metabolic Syndrome;   Insulin Resistance;   Dyslipidemia
Interventions: Other: Glucose;   Other: Fructose;   Other: High-Fructose Corn Syrup;   Other: No sugar (Aspartame)
6 Recruiting Effects of Food Form on Cephalic Phase Responses
Conditions: Obese;   Overweight
Interventions: Behavioral: Learned: Non-nutritive beverage to Non-nutritive beverage;   Behavioral: Learned: Nutritive solid to Nutritive solid;   Behavioral: Learned: Nutritive beverage to Nutritive beverage;   Behavioral: Not Learned: Non-nutritive solid to Nutritive solid;   Behavioral: Not Learned: Nutritive beverage to Non-nutritive beverage;   Behavioral: Not Learned: Non-Nutritive solid to Non-nutritive solid;   Behavioral: Not Learned: Non-nutritive beverage to Nutritive beverage;   Behavioral: Not Learned: Non-Nutritive solid to Non-Nutritive Solid
7 Not yet recruiting To Assess the Antiepileptic Efficacy of GWP42003-P in Children and Young Adults With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
8 Not yet recruiting A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome
Conditions: Epilepsy;   Dravet Syndrome;   Myoclonic Epilepsy
Interventions: Drug: GWP42003-P;   Drug: Placebo control
9 Recruiting A Double-Blind, Randomized, Controlled, Dose Escalation Clinical Trial of an Antiplaque Chewing Gum - Phase 1 Safety and Tolerability and Phase 2a Safety, Tolerability, and Proof of Concept in a Gingivitis Population
Conditions: Plaque;   Gingivitis
Interventions: Drug: 2 mg KSL-W;   Drug: 4 mg KSL-W;   Drug: 6 mg KSL-W;   Drug: 10 mg KSL-W;   Drug: 20 mg KSL-W;   Drug: 30 mg KSL-W;   Drug: 50 mg KSL-W;   Drug: 75 mg KSL-W;   Drug: 100 mg KSL-W;   Other: Placebo
10 Unknown  Dietary Intervention for Visceral Adiposity
Condition: Obesity
Interventions: Dietary Supplement: Benefiber;   Dietary Supplement: TrueLemon
11 Unknown  Middle Meatal Bacteriology During Acute Respiratory Infection in Children
Conditions: Acute Respiratory Infection;   Sinusitis
Interventions: Drug: placebo;   Drug: amoxicillin clavulanate acid

Indicates status has not been verified in more than two years